Business
PharmaCielo Announces Sales Agreement with Brazilian Phyto-Therapeutic Customer, and Key Management and Board Appointments
PharmaCielo Announces Sales Agreement with Brazilian Phyto-Therapeutic Customer, and Key ...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n \n \n \n PharmaCielo Announces Sales Agreement with Brazilian Phyto-Therapeutic Customer, and Key Management and Board Appointments\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n TORONTO\n \n and RIONEGRO, Colombia\n \n ,\n \n \n July 28, 2022\n \n \n /CNW/ - PharmaCielo Ltd. (\"PharmaCielo\" or the \"Company\") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of\n \n Colombia's\n \n premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. (\"Holdings\"), today announced a supply agreement (the \"Agreement\") with one of the largest phyto-therapeutic companies in the Brazilian market (the \"Customer\"). The Customer has an extensive distribution network across\n \n Latin America\n \n , and is also a certified B-Corp, reflecting its commitment to a transparent business model that measures social and environmental impacts.\n \n \n \n \n \n \n \n \n \n PharmaCielo will be registered with Anvisa as the sole supplier to the Customer for this product, and under the Agreement, PharmaCielo will ship significant quarterly volumes of a proprietary CBD derivative formulation to the Customer, which will be utilized in the production of novel herbal medicines to be distributed across\n \n Latin America\n \n . The Company expects to begin shipping during Q1 2023.\n \n \n \n Management Commentary\n \n \n \n \n \n Bill Petron\n \n \n ,\n \n CEO of PharmaCielo\n \n , commented, \"The efforts of PharmaCielo's recently strengthened and expanded sales force are paying off, with recent developments in\n \n Spain\n \n ,\n \n Poland\n \n ,\n \n Germany\n \n and\n \n Brazil\n \n . This customer is a well-established provider of unique, high quality herbal formulations aimed at the medical and wellness markets in\n \n Brazil\n \n , and is a perfect example of the type of product developer that we are seeking to build strong partnerships with to expand our global operations and generate recurring, long-term revenue. This agreement further validates our strategy to get into t...